Opens in a new tab

Disease Doesn’t Respect Boundaries. Our Diagnostics Shouldn’t Either.

Disease Doesn’t Respect Boundaries. Our Diagnostics Shouldn’t Either.

Health Without Borders

We live in a world where human, animal, plant and environmental health are intrinsically connected. A crop disease can threaten food security, livestock infections can impact animal welfare and health and disrupt trade and livelihoods, and environmental change can create new opportunities for disease emergence and spread. At the same time, growing resistance to antimicrobials and antiparasitic treatments is reducing the effectiveness of some of our most valuable disease-control tools.

Yet despite significant advances in diagnostic technology, many of the tools capable of supporting earlier detection and targeted interventions remain inaccessible, unaffordable or unavailable where decisions need to be made. The greatest barrier to progress may no longer be innovation, but implementation.

If disease does not respect boundaries, our diagnostic solutions cannot afford to either.

From Detection to Better Decisions

The true value of diagnostics lies not only in detecting disease, but in enabling better decisions. Across the One Health landscape, rapid and accessible testing can help shift disease management from reactive intervention to proactive prevention.

On farms, diagnostics can support the targeted use of interventions by identifying infection before clinical signs become widespread, reducing unnecessary treatment and helping to slow the emergence of resistance. In livestock, rapid tests can help monitor diseases and parasites such as liver fluke, enabling treatment only when needed rather than relying on routine prophylactic dosing. In crop production, diagnostics can help identify pathogen risk and disease pressure early, allowing growers to make more informed management decisions while reducing waste and spoilage. Similar approaches are also becoming increasingly important for the surveillance of transboundary animal diseases such as foot-and-mouth disease and lumpy skin disease, alongside emerging zoonotic threats including highly pathogenic avian influenza and Nipah virus, where early detection can be critical in limiting spread and protecting both animal and human health.

Whether supporting food security, disease surveillance, antimicrobial stewardship or outbreak preparedness, diagnostics place actionable information directly into the hands of those making decisions. However, their value is only realised when they are affordable, accessible and deployable at the point of need. Bridging the gap between technological capability and routine adoption remains one of the greatest opportunities to strengthen One Health outcomes.

The Cost of a Missed Diagnosis

Every delayed or missed diagnosis represents a lost opportunity to intervene early, contain disease, protect animal welfare, safeguard food production and reduce unnecessary treatment. Whether responding to a crop pathogen, managing parasitic infection in livestock, monitoring emerging zoonotic threats or strengthening outbreak preparedness, timely access to reliable and affordable diagnostic information enables faster, targeted and more sustainable action.

Diagnostics and Antimicrobial Resistance

This is particularly important in the fight against antimicrobial resistance (AMR), where diagnostics can help ensure that the correct treatments are used only when needed and where they are most likely to be effective. The consequences of resistance are felt across the One Health spectrum. Drug-resistant bovine tuberculosis (Mycobacterium bovis), a zoonotic pathogen that remains a significant challenge in many parts of Africa, highlights the complex links between animal and human health. Likewise, the emergence of triclabendazole-resistant liver fluke parasite highlights the interconnected nature of One Health, reducing the effectiveness of a treatment relied upon to control fascioliasis in both animals and humans.

The Growing Threat of Fungal Pathogens

Fungal pathogens provide another stark example. Reported to be responsible for more than a billion human infections and over 1.6 million deaths globally each year, they pose an increasing threat to both agriculture and public health. Growing resistance to azoles is particularly concerning, as related compounds are relied upon both to protect crops and to treat serious fungal infections in humans.

From Innovation to Implementation

However, a technically excellent diagnostic is only valuable if people use it. Adoption depends on clear economic value, regulatory or societal drivers, whether that is reducing losses, improving productivity, supporting antimicrobial stewardship, meeting certification requirements or strengthening disease surveillance. As disease pressures intensify through globalisation, climate change and increasing antimicrobial resistance, diagnostics must become as affordable, accessible and deployable as the threats they are designed to detect.

Disease doesn’t wait. Neither can our ability to turn diagnostic innovation into real-world impact.

Work with GADx

Accelerating One Health diagnostics together

We’re keen to collaborate with researchers, funders, commercial partners and innovators working to accelerate the development and implementation of accessible diagnostic solutions across the One Health landscape.

References

Get In Touch

Frequent testing is invaluable and so it is vital to find ways to drive down the cost of kits and increase production levels. As a social enterprise, GADx can transform this process because it ‘breaks the link’ of ‘having to make profit for shareholders’.

Paul Davis
Co-founder of Mologic and pioneer of lateral flow diagnostics.